Today: 27 March 2026
Subscribe
Browse Category

NASDAQ:ZEAL 6 March 2026

Zealand Pharma A/S shares plunge as petrelintide results trail Lilly in obesity race

Zealand Pharma A/S shares plunge as petrelintide results trail Lilly in obesity race

Zealand Pharma shares fell 32.53% to 249.10 Danish crowns by mid-morning Friday after new data for its obesity drug petrelintide disappointed investors, erasing about 8.3 billion crowns ($1.3 billion) in market value. A Phase 2 study showed up to 10.7% weight loss over 42 weeks, well below results seen with Eli Lilly’s rival drug. No vomiting or discontinuations due to gastrointestinal side effects were reported.
6 March 2026
·

Stock Market Today

  • Costamare Shares Surge Above 200-Day Moving Average on NYSE
    March 27, 2026, 5:37 AM EDT. Costamare Inc. (NYSE:CMRE) stock price climbed above its 200-day moving average of $14.84, reaching $16.8560 on Thursday with 493,277 shares changing hands. Despite a recent earnings miss-$0.60 per share versus $0.74 expected-and a 6.9% drop in quarterly revenue, Costamare's net margin stands strong at 33.19%. Analysts remain cautious; Weiss Ratings and Wall Street Zen recently downgraded the stock to 'hold,' with a consensus price target of $12.00. The firm paid a quarterly dividend of $0.115, yielding 2.7%. Institutional investors increased holdings notably, including Caitong International Asset Management and Mackenzie Financial. Costamare's market cap is $2.03 billion, with a P/E ratio of 5.91 and a beta of 1.21, indicating moderate volatility. The stock's advance above long-term technical support signals growing investor confidence amid mixed fundamentals.
Go toTop